Better Coronavirus Stock: Emergent Biosolutions vs. Regeneron

Shares of Emergent Biosolutions (NYSE: EBS) and Regeneron (NASDAQ: REGN) have risen sharply in 2020 thanks to potential coronavirus drugs in development, but that's where their similarities end. Is Emergent, a company with government contracts to produce vaccines for other drugmakers, a better stock to buy now than Regeneron, a biotechnology pioneer with several blockbuster drugs under its belt? Over the past decade, Emergent Biosolutions has become the U.S. government's favorite contractor for infectious disease catastrophe preparation services.